记者从国家药监局获悉，12月29日，国家药监局在石家庄召开化妆品监管工作座谈会，总结2025年监管 工作成效，分析当前形势，研究2026年重点工作思路。国家药监局党组成员、副局长徐景和出席会议并 讲话。 会议强调，2026年是"十五五"规划开局之年，要深入贯彻落实党的二十大和二十届历次全会精神，按照 国家药监局的统一部署，围绕中心、突出重点，持续深化全过程监管改革，全方位筑牢安全底线，全链 条促进化妆品产业高质量发展。国家药监局相关司局、直属单位，部分省(市)药监局代表参加会议。 在石家庄期间，徐景和到河北省药品医疗器械检验研究院、省医疗器械技术审评中心和省药品监督管理 学会实地调研。(经济日报记者佘惠敏) ...

智通财经APP获悉，12月29日，国家药监局在石家庄召开化妆品监管工作座谈会，总结2025年监管工作 成效，分析当前形势，研究2026年重点工作思路。会议强调，2026年是"十五五"规划开局之年，要深入 贯彻落实党的二十大和二十届历次全会精神，按照国家药监局的统一部署，围绕中心、突出重点，持续 深化全过程监管改革，全方位筑牢安全底线，全链条促进化妆品产业高质量发展。 12月29日，国家药监局在石家庄召开化妆品监管工作座谈会，总结2025年监管工作成效，分析当前形 势，研究2026年重点工作思路。国家药监局党组成员、副局长徐景和出席会议并讲话。 会议强调，2026年是"十五五"规划开局之年，要深入贯彻落实党的二十大和二十届历次全会精神，按照 国家药监局的统一部署，围绕中心、突出重点，持续深化全过程监管改革，全方位筑牢安全底线，全链 条促进化妆品产业高质量发展。国家药监局相关司局、直属单位，部分省(市)药监局代表参加会议。 在石家庄期间，徐景和到河北省药品医疗器械检验研究院、省医疗器械技术审评中心和省药品监督管理 学会实地调研。 本文编选自"国家药监局"官网，智通财经编辑：冯秋怡。 原文如下： 国家药监局召开化妆 ...

Core Insights - The Chinese beauty industry is entering a new phase of policy explosion, with over 102 new regulations released since 2025, covering key aspects such as raw material innovation, registration, quality supervision, and personalized services, indicating a strategic shift from a "cosmetic manufacturing country" to a "cosmetic powerhouse" [1][71][96] Industry Overview - The total transaction value of the Chinese cosmetics market is projected to reach 1,073.822 billion yuan in 2024, making it the largest consumer market globally [4][71] - As of October 2025, there are over 20,000 registered cosmetic companies and 2,291,000 registered ordinary cosmetics in China [4][71] Regional Policies - Major production areas like Guangdong, Shanghai, Hainan, and Zhejiang have introduced targeted policies that leverage local industrial advantages, focusing on compliance and industry empowerment [4][72] - Guangdong has implemented a "strict regulation + strong support" policy, enhancing production compliance and providing substantial financial incentives for innovation [26][91] - Shanghai emphasizes its role as a "R&D hub + international window," with policies aimed at brand cultivation and innovation support [93] Specific Initiatives - Guangdong's policies include a one-time funding of up to 1 million yuan for approved national key laboratories and 100,000 yuan for new raw material registrations [92] - Shanghai's measures offer up to 200,000 yuan for new raw materials and 3 million yuan for projects promoting "Shanghai-made brands" [93][81] - Hainan is focusing on developing local resources like pearls and coconuts, with a special support policy for the cosmetics industry, offering up to 30 million yuan in direct funding [94][87] Regulatory Reforms - The National Medical Products Administration (NMPA) has released 20 core new policies since 2025, focusing on deepening regulatory reforms and activating innovation [96][97] - Key reforms include the introduction of a risk monitoring and evaluation management method, which shifts regulatory focus from post-event handling to proactive prevention [34][98] - The NMPA aims to achieve an internationally advanced level of cosmetic quality and safety regulation by 2035, with 24 reform measures targeting raw material innovation and registration efficiency [96][98] Technical Standards - The China National Institute of Standardization has published at least 65 technical standards and guidelines for cosmetics this year, providing essential technical support for regulatory compliance [53][54] - These standards aim to fill critical gaps in the regulatory framework, ensuring quality control and safety in the cosmetics market [53][54]

国家药监局近日发布《关于深化化妆品监管改革促进产业高质量发展的意见》（以下简称《意见》）， 国家药监局化妆品监管司有关负责人就《意见》的相关情况接受记者采访。 随着我国人口老龄化程度持续加深，老年群体对化妆品的需求日益增长且日趋多元化。《意见》明确， 鼓励企业加强"银发族"化妆品的技术研发，支持开展皮肤衰老机理等前沿基础研究，为技术创新提供科 学支撑。同时，支持适合老年群体特点和需求的化妆品开发，在确保安全与功效的前提下加速其注册备 案与上市进程。 该负责人表示，《意见》的发布，旨在进一步增强监管改革的系统性、整体性和协调性，全过程深化化 妆品监管改革，全方位筑牢化妆品安全底线，全链条支持化妆品产业高质量发展，加快推进我国从"制 妆大国"向"制妆强国"跨越，切实增进人民群众在化妆品领域的获得感、幸福感、安全感。 为适应化妆品产业智能化、绿色化发展需求，《意见》明确提出要加快实施化妆品电子标签。国家药监 局拟于2026年2月起在部分省（市）开展电子标签试点工作。 《意见》提出，到2030年，化妆品监管法律制度更加完善，标准体系更加健全，技术支撑更加有力，产 业创新活力更加充沛，风险防控能力全面加强，质量安全水平 ...

Core Viewpoint - The new regulatory reforms introduced by the National Medical Products Administration aim to enhance the quality and competitiveness of the cosmetics industry in China, with a vision for modernization and international alignment by 2035 [2][7]. Group 1: Regulatory Reforms - The "Opinions" document outlines 24 reform proposals and 48 specific measures to improve the cosmetics industry [3]. - Key measures include the establishment of a fast-track approval process for new efficacy cosmetics, allowing international new products to enter the market without prior sales proof, and fostering the silver economy by addressing the needs of the elderly [4][5]. Group 2: Innovation and Market Dynamics - The reforms focus on the front end of the industry value chain, emphasizing innovation, product entry, and market introduction [4]. - The introduction of a dedicated review channel for new efficacy cosmetics is expected to lower R&D costs and provide clear policy guidance for companies [4]. Group 3: Digitalization and Efficiency - New electronic labeling initiatives are set to enhance regulatory digitalization, allowing consumers to access comprehensive product information via QR codes [6]. - Measures to streamline the review process include reducing the review time for high-risk changes from 90 to 60 days and for low-risk changes to 45 days, significantly improving efficiency [6]. Group 4: Quality Management and Market Growth - A three-year action plan will be implemented to enhance the quality management systems of cosmetics companies, particularly benefiting small and medium-sized enterprises [7]. - The Chinese cosmetics market is projected to exceed 1 trillion yuan in transaction value by 2024, with domestic products accounting for over 55.2% of sales [7].

Core Viewpoint - The National Medical Products Administration (NMPA) has released an opinion aimed at deepening the reform of cosmetics regulation and promoting high-quality development in the industry over the next 5 to 10 years, with 24 reform measures proposed to enhance safety and innovation in the cosmetics sector [1][2]. Group 1: Industry Overview - China is the world's largest cosmetics market, with over 20,000 cosmetics companies and 4.6 million registered special cosmetics varieties, alongside 2.29 million filed ordinary cosmetics varieties [1]. - The domestic cosmetics market is projected to exceed 1 trillion yuan in transaction volume by 2024, with domestic brands holding a market share of 55.2% [1]. Group 2: Reform Measures - The opinion outlines 24 reform measures focusing on five areas: encouraging innovation, optimizing registration and filing management, strengthening risk prevention across the supply chain, enhancing smart regulatory capabilities, and aligning regulations with international standards [2]. - Specific measures include supporting raw material innovation, establishing a classification management and technical evaluation system for new raw materials, and creating a collaborative mechanism for research and evaluation [2]. Group 3: Regulatory Changes - A specialized review channel for new efficacy cosmetics will be established, allowing for immediate review upon submission and providing pre-consultation for registration applications [3]. - The opinion allows international cosmetics that meet certain criteria to bypass the requirement of submitting proof of prior market approval, facilitating faster market entry for new products [3]. Group 4: Registration and Filing Reform - The opinion proposes specific measures to simplify registration and filing management, such as allowing similar products from the same brand to share safety and efficacy evaluation data and reducing the registration burden for products changing production locations [4]. - The review mechanism will be optimized, with high-risk registration changes being processed in 60 working days and low-risk changes in 45 working days, significantly improving approval efficiency [4].

Core Viewpoint - The National Medical Products Administration (NMPA) has released a set of opinions aimed at deepening cosmetic regulation reform and promoting high-quality development in the industry, focusing on safety, innovation, and market expansion [1] Group 1: Regulatory Reforms - The opinions propose a comprehensive reform plan for the next 5 to 10 years, including 24 reform suggestions and 48 specific measures to enhance category innovation, regulatory optimization, and industry empowerment [1] - A special review channel for new efficacy cosmetics will be established, allowing for immediate review upon submission, which aims to reduce the high trial-and-error costs previously faced by companies [3] Group 2: Market Expansion - The introduction of a policy allowing international cosmetic products to launch in China without prior sales license documentation is expected to create a "fast track" for new products, significantly boosting consumer access to global innovations [4] - The domestic cosmetic market is projected to exceed 1 trillion yuan in transaction volume by 2024, with domestic brands holding a market share of 55.2% [1] Group 3: Targeting Demographic Needs - The opinions emphasize the development of cosmetics tailored for the aging population, encouraging companies to focus on research related to skin aging and to expedite the registration and listing processes for these products [5] - The growing demand from the elderly demographic is recognized as a significant opportunity for innovation within the industry [5] Group 4: Digital Transformation - The NMPA is advancing the digital upgrade of cosmetic regulation, with a focus on implementing electronic labels to enhance product information accessibility for consumers [6][7] - The digital labels will allow consumers to easily access detailed product information through various formats, improving readability and catering to diverse consumer needs [7]

Core Viewpoint - The National Medical Products Administration of China has issued opinions to deepen cosmetic regulation reform and promote high-quality industry development, emphasizing support for the cosmetic industry and encouraging the launch of new products in China [1] Industry Summary - The Chinese cosmetic industry is transitioning from scale expansion to a high-quality phase driven by technology, efficacy, and sustainable development [1] - The market size of the cosmetic industry is projected to reach 1,073.8 billion yuan in 2024, with a steady growth rate of 5%-10% expected over the next five years [1] - Domestic brands have surpassed a 55% market share, leveraging Eastern aesthetic systems to promote cultural confidence and commercial value transformation [1] - The future of the cosmetic industry in China will focus on building competitive barriers through a "full industry chain ecosystem," enhancing research and development, deepening Eastern cultural aesthetics, and expanding global presence [1] Company Summary - Relevant A-share concept stocks mentioned include Beitaini and Shuiyang Co., Ltd. [1]

Core Viewpoint - The article discusses the recent developments in the financial sector, highlighting the impact of regulatory changes and market dynamics on investment strategies and opportunities [1]. Group 1: Regulatory Changes - New regulations are being implemented that could significantly alter the landscape for investment banks, affecting their operational strategies and compliance costs [1]. - The regulatory environment is becoming increasingly stringent, which may lead to a consolidation of smaller firms as they struggle to meet new requirements [1]. Group 2: Market Dynamics - Recent market trends indicate a shift towards sustainable investing, with a growing number of investors prioritizing environmental, social, and governance (ESG) factors in their decision-making processes [1]. - The financial sector is witnessing increased volatility, which presents both challenges and opportunities for investment banks to adapt their strategies accordingly [1].

Core Viewpoint - The National Medical Products Administration (NMPA) has released a set of opinions aimed at deepening cosmetic regulation reform and promoting high-quality development in the industry, focusing on safety, innovation, and market expansion [1][2]. Group 1: Regulatory Reforms - The NMPA will establish a special review channel for new efficacy cosmetics, implementing an "immediate report and review" system to streamline the approval process and support innovative research [2][3]. - The opinions include 24 reform suggestions and 48 specific measures to enhance category innovation, regulatory optimization, and industry empowerment [1]. Group 2: Market Expansion - The new policies aim to make China a global launch hub for new cosmetic products by allowing international brands to bypass certain licensing requirements, thus accelerating their entry into the Chinese market [3]. - The domestic cosmetic market is projected to exceed 1 trillion yuan in transaction volume by 2024, with domestic brands holding a market share of 55.2% [1]. Group 3: Silver Economy - The opinions emphasize the development of cosmetics tailored for the elderly, encouraging companies to focus on research related to skin aging and to expedite the registration and listing processes for these products [3][4]. - The potential of the silver economy is recognized as a significant growth area, with specialized products for older consumers becoming a key innovation track [4]. Group 4: Digital Transformation - The NMPA plans to implement electronic labeling for cosmetics, enhancing information accessibility and consumer understanding through digital formats [4][5]. - The regulatory framework will be optimized to reduce the burden on companies, focusing resources on high-risk areas while ensuring a non-intrusive regulatory environment [5].